Germany
· Delayed Price · Currency is EUR FRA:HCG Statistics
Total Valuation
FRA:HCG has a market cap or net worth of EUR 14.79 billion. The enterprise value is 21.83 billion.
| Market Cap | 14.79B |
| Enterprise Value | 21.83B |
Important Dates
The next estimated earnings date is Friday, May 16, 2025.
| Earnings Date | May 16, 2025 |
| Ex-Dividend Date | Jun 6, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 10.85B |
Valuation Ratios
The trailing PE ratio is 20.82.
| PE Ratio | 20.82 |
| Forward PE | n/a |
| PS Ratio | 2.14 |
| PB Ratio | 1.74 |
| P/TBV Ratio | 2.24 |
| P/FCF Ratio | 46.36 |
| P/OCF Ratio | 13.21 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.93, with an EV/FCF ratio of 68.46.
| EV / Earnings | 30.74 |
| EV / Sales | 3.47 |
| EV / EBITDA | 13.93 |
| EV / EBIT | 18.78 |
| EV / FCF | 68.46 |
Financial Position
The company has a current ratio of 0.67, with a Debt / Equity ratio of 0.86.
| Current Ratio | 0.67 |
| Quick Ratio | 0.49 |
| Debt / Equity | 0.86 |
| Debt / EBITDA | 5.02 |
| Debt / FCF | 22.97 |
| Interest Coverage | 3.62 |
Financial Efficiency
Return on equity (ROE) is 9.70% and return on invested capital (ROIC) is 3.97%.
| Return on Equity (ROE) | 9.70% |
| Return on Assets (ROA) | 3.19% |
| Return on Invested Capital (ROIC) | 3.97% |
| Return on Capital Employed (ROCE) | 6.69% |
| Revenue Per Employee | 122,305 |
| Profits Per Employee | 12,593 |
| Employee Count | 56,401 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 12.07 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.35% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +15.35% |
| 50-Day Moving Average | 0.75 |
| 200-Day Moving Average | 0.73 |
| Relative Strength Index (RSI) | 56.64 |
| Average Volume (20 Days) | 270 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:HCG had revenue of EUR 6.90 billion and earned 710.23 million in profits. Earnings per share was 0.04.
| Revenue | 6.90B |
| Gross Profit | 2.87B |
| Operating Income | 1.02B |
| Pretax Income | 1.06B |
| Net Income | 710.23M |
| EBITDA | 1.44B |
| EBIT | 1.02B |
| Earnings Per Share (EPS) | 0.04 |
Balance Sheet
The company has 956.46 million in cash and 7.33 billion in debt, giving a net cash position of -6.37 billion.
| Cash & Cash Equivalents | 956.46M |
| Total Debt | 7.33B |
| Net Cash | -6.37B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 8.50B |
| Book Value Per Share | 0.38 |
| Working Capital | -1.46B |
Cash Flow
In the last 12 months, operating cash flow was 1.12 billion and capital expenditures -800.26 million, giving a free cash flow of 318.94 million.
| Operating Cash Flow | 1.12B |
| Capital Expenditures | -800.26M |
| Free Cash Flow | 318.94M |
| FCF Per Share | n/a |
Margins
Gross margin is 41.66%, with operating and profit margins of 14.74% and 10.30%.
| Gross Margin | 41.66% |
| Operating Margin | 14.74% |
| Pretax Margin | 15.31% |
| Profit Margin | 10.30% |
| EBITDA Margin | 20.86% |
| EBIT Margin | 14.74% |
| FCF Margin | 4.62% |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 5.35%.
| Dividend Per Share | 0.04 |
| Dividend Yield | 5.35% |
| Dividend Growth (YoY) | -1.25% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 114.35% |
| Buyback Yield | n/a |
| Shareholder Yield | 5.35% |
| Earnings Yield | 4.80% |
| FCF Yield | 2.16% |
Stock Splits
The last stock split was on June 4, 2021. It was a forward split with a ratio of 1.05000105.
| Last Split Date | Jun 4, 2021 |
| Split Type | Forward |
| Split Ratio | 1.05000105 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |